321 related articles for article (PubMed ID: 28618998)
1. The Role of Mitochondrial Dysfunction in the Progression of Alzheimer's Disease.
Desler C; Lillenes MS; Tønjum T; Rasmussen LJ
Curr Med Chem; 2018; 25(40):5578-5587. PubMed ID: 28618998
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial Dysfunction: a Potential Therapeutic Target to Treat Alzheimer's Disease.
Rai SN; Singh C; Singh A; Singh MP; Singh BK
Mol Neurobiol; 2020 Jul; 57(7):3075-3088. PubMed ID: 32462551
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of Mitochondrial Dysfunction in Alzheimer's Disease.
Cadonic C; Sabbir MG; Albensi BC
Mol Neurobiol; 2016 Nov; 53(9):6078-6090. PubMed ID: 26537901
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress and altered mitochondrial protein expression in the absence of amyloid-β and tau pathology in iPSC-derived neurons from sporadic Alzheimer's disease patients.
Birnbaum JH; Wanner D; Gietl AF; Saake A; Kündig TM; Hock C; Nitsch RM; Tackenberg C
Stem Cell Res; 2018 Mar; 27():121-130. PubMed ID: 29414602
[TBL] [Abstract][Full Text] [Related]
5. The mitochondrial spiral. An adequate cause of dementia in the Alzheimer's syndrome.
Blass JP
Ann N Y Acad Sci; 2000; 924():170-83. PubMed ID: 11193795
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial dysfunction in the APP/PSEN1 mouse model of Alzheimer's disease and a novel protective role for ascorbate.
Dixit S; Fessel JP; Harrison FE
Free Radic Biol Med; 2017 Nov; 112():515-523. PubMed ID: 28863942
[TBL] [Abstract][Full Text] [Related]
7. Emerging perspectives on mitochondrial dysfunction and inflammation in Alzheimer's disease.
Yoo SM; Park J; Kim SH; Jung YK
BMB Rep; 2020 Jan; 53(1):35-46. PubMed ID: 31818363
[TBL] [Abstract][Full Text] [Related]
8. Molecular pathophysiology of impaired glucose metabolism, mitochondrial dysfunction, and oxidative DNA damage in Alzheimer's disease brain.
Abolhassani N; Leon J; Sheng Z; Oka S; Hamasaki H; Iwaki T; Nakabeppu Y
Mech Ageing Dev; 2017 Jan; 161(Pt A):95-104. PubMed ID: 27233446
[TBL] [Abstract][Full Text] [Related]
9. Vascular factors and mitochondrial dysfunction: a central role in the pathogenesis of Alzheimer's disease.
Orsucci D; Mancuso M; Ienco EC; Simoncini C; Siciliano G; Bonuccelli U
Curr Neurovasc Res; 2013 Feb; 10(1):76-80. PubMed ID: 23151073
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's pathogenesis and its link to the mitochondrion.
Simoncini C; Orsucci D; Caldarazzo Ienco E; Siciliano G; Bonuccelli U; Mancuso M
Oxid Med Cell Longev; 2015; 2015():803942. PubMed ID: 25973139
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial Dysfunction as a Predictor and Driver of Alzheimer's Disease-Like Pathology in OXYS Rats.
Tyumentsev MA; Stefanova NA; Muraleva NA; Rumyantseva YV; Kiseleva E; Vavilin VA; Kolosova NG
J Alzheimers Dis; 2018; 63(3):1075-1088. PubMed ID: 29710722
[TBL] [Abstract][Full Text] [Related]
12. CR6-interacting factor 1 is a key regulator in Aβ-induced mitochondrial disruption and pathogenesis of Alzheimer's disease.
Byun J; Son SM; Cha MY; Shong M; Hwang YJ; Kim Y; Ryu H; Moon M; Kim KS; Mook-Jung I
Cell Death Differ; 2015 Jun; 22(6):959-73. PubMed ID: 25361083
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial dysfunction and Alzheimer's disease.
Maruszak A; Żekanowski C
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):320-30. PubMed ID: 20624441
[TBL] [Abstract][Full Text] [Related]
14. Defective mitochondrial respiration, altered dNTP pools and reduced AP endonuclease 1 activity in peripheral blood mononuclear cells of Alzheimer's disease patients.
Maynard S; Hejl AM; Dinh TS; Keijzers G; Hansen ÅM; Desler C; Moreno-Villanueva M; Bürkle A; Rasmussen LJ; Waldemar G; Bohr VA
Aging (Albany NY); 2015 Oct; 7(10):793-815. PubMed ID: 26539816
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress, mitochondrial dysfunction, and stress signaling in Alzheimer's disease.
Onyango IG; Khan SM
Curr Alzheimer Res; 2006 Sep; 3(4):339-49. PubMed ID: 17017864
[TBL] [Abstract][Full Text] [Related]
16. Characterization of mitochondrial dysfunction in the 7PA2 cell model of Alzheimer's disease.
Krako N; Magnifico MC; Arese M; Meli G; Forte E; Lecci A; Manca A; Giuffrè A; Mastronicola D; Sarti P; Cattaneo A
J Alzheimers Dis; 2013; 37(4):747-58. PubMed ID: 23948918
[TBL] [Abstract][Full Text] [Related]
17. March separate, strike together--role of phosphorylated TAU in mitochondrial dysfunction in Alzheimer's disease.
Eckert A; Nisbet R; Grimm A; Götz J
Biochim Biophys Acta; 2014 Aug; 1842(8):1258-66. PubMed ID: 24051203
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial Dysfunction in Neocortex and Hippocampus of Olfactory Bulbectomized Mice, a Model of Alzheimer's Disease.
Avetisyan AV; Samokhin AN; Alexandrova IY; Zinovkin RA; Simonyan RA; Bobkova NV
Biochemistry (Mosc); 2016 Jun; 81(6):615-23. PubMed ID: 27301290
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial alterations, oxidative stress and neuroinflammation in Alzheimer's disease.
Verri M; Pastoris O; Dossena M; Aquilani R; Guerriero F; Cuzzoni G; Venturini L; Ricevuti G; Bongiorno AI
Int J Immunopathol Pharmacol; 2012; 25(2):345-53. PubMed ID: 22697066
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC
J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
